AlphaGrep UK’s CVS Health CVS Stock Holding History

AlphaGrep UK’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,738	Closed	-$268K	–	782
2026 Q1	$268K	Buy	+3,738	New	+$288K	0.08%	564

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AlphaGrep UK's CVS Position: Q2 2026 in Review

AlphaGrep UK sold out of CVS Health (CVS) in Q2 2026, closing a stake of 3,738 shares — an estimated $268K sold.

AlphaGrep UK first reported a position in CVS in Q1 2026 and held it in 1 quarter. The position peaked at $268K in Q1 2026. 1,975 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

AlphaGrep UK reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 3,738 CVS Health shares in Q2 2026, an estimated $268K.
AlphaGrep UK first reported a position in CVS Health in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's CVS Health position peaked at $268K in Q1 2026.
1,975 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.